Last week, Celsius Therapeutics announced an additional $83M USD in financing and we are excited to be a part of this syndicate. …

Science and gender equality are both vital for the achievement of the United Nations internationally agreed sustainable development goals. Globally, only 33 percent of researchers are women, and they are awarded less research funding than men and are less likely to be promoted. In the private sector too, women are…

This week, Congruence announced the close of a $50M US Series A financing. This is a great example of Amplitude’s strategy to support early-stage companies from a concept to a well-financed business with a diverse and experienced management team and a great group of investors. Congruence is tackling rare diseases…

Gandeeva recently announced a $40M US round of financing. We are extremely excited to join the other syndicate members in building another world-leading company in Canada. …

This week, Valence announced the close of a $7M oversubscribed series seed financing. Amplitude is investing to support the company advance its AI-first chemistry design platform, scale its partnerships with leading drug discovery organizations, further expand the team and advance its own internal drug discovery programs. AI is an increasingly…

This week Prilenia announced the close of a $43M US oversubscribed and upsized Series B Financing. Amplitude decided to support the company to advance their lead program, Pridopidine, through Phase 3 clinical trials in Huntington’s disease and a phase 2/3 study in ALS. The company was founded in September 2018…

Today LQT Therapeutics announced the close of $19M US Series A Financing. We’re excited to lead this financing to build a company pioneering the development of precision therapies for genetic heart disease. LQT is another example of Amplitude’s strategy of creating, building, and growing innovative precision medicine companies. The company…

This week, Deep Genomics announced the closing of a $180 million USD Series C Financing Round, one of the largest-ever funding rounds for a Canadian-based biotech business. We’re excited to be a part of this fantastic syndicate, led by Softbank with additional investment by CPPIB, Fidelity and existing investors. AI…

We are pleased to announce an over-subscribed final close for Amplitude Ventures Fund I. In June 2018, we announced the audacious goal of raising a $200M Precision Medicine fund focused primarily on Canadian innovation. Given the historical size of life sciences funds in Canada, this was very aspirational. After years…